World Medicine

What World Medicine does

World Medicine is a privately held international pharmaceutical company headquartered in London, United Kingdom, with primary operating assets in Türkiye and Algeria. The company develops, manufactures, and sells over 500 pharmaceutical products across eight therapeutic areas (ophthalmology, neurology, endocrinology, cardiology, rheumatology, gastroenterology, urology, and pulmonology), as well as food supplements and vitamins, distributed in 65+ countries. Operations span four EU-GMP certified production facilities (three in Türkiye including a flagship 50,000 m² Cerkezköy plant with 1.3 billion boxes/year capacity, plus a Cerkezköy-2 facility and an Istanbul facility) and one in Oran, Algeria, with a fifth facility under construction in Uzbekistan. World Medicine's revenue model combines (i) branded and generic pharmaceutical product sales through direct sales teams in 12 markets and distribution partners in 23+ additional markets, (ii) contract manufacturing services for UK and EU-based pharmaceutical companies, and (iii) licensing and technology transfer, including out-licensing of EMA-standardised e-CTD dossiers to partners in UK, ANZ, Canada, EU, and CIS regions. The company is a recognized R&D leader in Türkiye (ranked 1st in pharmaceutical R&D project count, 2nd nationally), holding 3,000+ international trademark and patent applications, and was Türkiye's leading pharmaceutical exporter by 2024 sales.

The business is supported by a vertically integrated operating model that includes a multi-unit R&D Center (WMARGE) covering product development, analytical development, technology transfer, science, CTD and technical documentation, patent, clinical research, and project operations, alongside the WMINOLAB analytical testing subsidiary and the WM Academy corporate training platform. Certifications include EU-GMP, ISO 9001, 14001, 27001, 13485, 45001, 50001, 17025, AEO, and I-REC renewable energy certification. World Medicine is registered as World Medicine Limited in England and Wales and operates as part of the World Medicine Group Companies, with no disclosed private equity, venture capital, or institutional investor ownership.

Name

World Medicine

Legal name

World Medicine Limited

Website

https://worldmedicine.co.uk

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

World Medicine is a UK-headquartered, privately held international pharmaceutical company that develops, manufactures, and distributes 500+ generic and branded pharmaceutical products across 65+ countries through four EU-GMP certified production facilities in Türkiye and Algeria, with a fifth facility under construction in Uzbekistan.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Third-Party/Outsourced Quality & Responsible Person Services (EU QP/RP, US Agent) (HLAGAKAO), Specialty Pharmaceutical Distributors (HLAIAJAB), Ophthalmology Specialty Pharmaceuticals (HLAIACAK), Ophthalmology Pharmaceuticals (HLAIAAAL)

Keywords

• Generic pharmaceuticals
• Pharmaceutical manufacturing
• Contract manufacturing services
• Ophthalmic medications
• Pharmaceutical exports

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sale of 500+ pharmaceutical products across 65+ countries in therapeutic areas including ophthalmology, neurology, endocrinology, cardiology, rheumatology, gastroenterology, urology and pulmonology. Products include medications, medical devices, food supplements and vitamins.
2. Contract Manufacturing Services: Manufacturing services provided to UK and EU-based pharmaceutical companies through 4 GMP-certified production facilities in Türkiye and Algeria. Includes manufacturing, quality control, packaging, storage, and global regulatory support.
3. Licensing and Technology Transfer: Transfer of technology and research licenses, out-licensing of EMA-standardised e-CTD Dossiers to potential partners within UK, ANZ, Canada, EU, and CIS regions.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

World Medicine is an international pharmaceutical company that develops, manufactures and sells 500+ generic pharmaceutical products, medical devices, food supplements and vitamins across eight therapeutic areas (ophthalmology, neurology, endocrinology, cardiology, rheumatology, gastroenterology, urology and pulmonology). The company operates four EU-GMP certified production facilities in Türkiye and Algeria and sells to 65+ countries through a hybrid model of direct sales teams and distribution partners. It also offers contract manufacturing services to UK and EU-based pharmaceutical companies and licenses EMA-standardised dossiers to partners worldwide.

Product overview

World Medicine is a pharmaceutical company offering a diverse portfolio of over 500 pharmacological products spanning multiple therapeutic areas including ophthalmology, neurology, endocrinology, cardiology, rheumatology, gastroenterology, urology, and pulmonology. The company's product offerings comprise two main categories: Medications and Medical Devices (including cardiovascular drugs like AKTAZID, AMLIPIN; ophthalmic products like APFECTO, EYENAT; respiratory medications like BEKLOMIL, FLUTEL; antibiotics like CEFAMED, ROTACEF; and others across musculoskeletal, antifungal, antiviral, and gastrointestinal treatments), and Food Supplements and Vitamins (including AEROLET herbal cough syrup, C-MUN vitamin C supplements, CARBIEM L-Carnitine, ENGILEN turmeric supplements, GOLD RAY royal jelly capsules, IMMUNACTIVE, PROSYN probiotics, and WM-D3 vitamin D3). Supporting the product portfolio, World Medicine provides Contract Manufacturing Services utilizing EU-GMP certified facilities in Türkiye and Algeria, and operates the WM R&D Center (WMARGE) with multiple specialized units including Analytical Development Laboratories, Product Development Services, Technology Transfer, Science Department, WM Academy for employee training, YOGA competence assessment, and Quality Control Laboratories. The company maintains 4 production facilities across Türkiye (Istanbul, Cerkezköy, Cerkezköy-2) and Algeria.

Differentiator

Problem solved

Functional benefit

Brands

• WM Ophthalmics: Subsidiary focused on ophthalmic products.
• WMINOLAB
• WM Academy
• YOGA

Products and services

• AKTAZID
• AMLIPIN Film-coated tablet combining Amlodipine and Lisinopril, available in 5mg/10mg and 10mg/10mg dosages, for cardiovascular conditions.
• APFECTO Eye drop suspension containing Nepafenac at 0.1% and 0.3% concentrations, presented in 5ml and 1.7ml drop formats, for ophthalmic treatment.
• ARTROCOL Topical gel formulation containing 2.5% Ketoprofen, presented in 45g containers, for musculoskeletal system treatment.
• BEFIXO IM injectable solution containing B vitamins (Thiamine hydrochloride, Pyridoxine hydrochloride, Cyanocobalamin, Riboflavin sodium phosphate), presented as 5 ampoules of 3ml.
• BEKLOMIL Nasal spray suspension containing Beclomethasone Dipropionate at 100mcg, available in 120 and 200 dose presentations, for respiratory system conditions.
• BIVOXA Eye drop solution containing 0.5% Moxifloxacin Hydrochloride, for ophthalmic infections.
• CARMETADIN Modified-release tablet containing 35mg Trimetazidine Dihydrochloride, presented as 60 tablets.
• CEFAMED Powder for injection containing Ceftriaxone Sodium, available in 0.5g and 1g I.M. presentations, packaged as 1 or 3 vials, used as an antibacterial agent.
• CELGYN Tablet formulation containing 200mg Celecoxib, for pain and inflammation management.
• CLODIFEN Topical gel containing 5% Diclofenac Sodium, presented in 45g containers.
• DAPORIN Film-coated tablet containing Dapoxetine at 30mg and 60mg dosages, presented in 3 or 6 tablet packs, for genito-urinary system conditions.
• DEFEJACT Dispersible tablet containing 500mg Deferasirox, presented as 28 tablets, used for hematological conditions (iron chelation).
• DICLASIL Tablet formulation containing Tadalafil at 5mg and 20mg dosages, presented in 14 or 28 tablet packs, for genito-urinary system conditions.
• DORAMYCIN Tablet containing 3,000,000 I.U. Spiramycin, presented as 10 tablets.
• DORZASOPT Eye drop formulation combining 2% Dorzolamide Hydrochloride with 0.5% Timolol Maleate, for glaucoma treatment.
• EMEKSAT Eye drop suspension containing 0.05% Emedastine Difumarate, presented in 5ml containers.
• ENZOFEN Topical cream containing 2% Fenticonazole Nitrate, presented in 30g containers; also available as 600mg vaginal capsules in 2-capsule packs.
• EYENAT Eye drop solution containing 0.15% Sodium Hyaluronate, presented in 10ml containers.
• FLUBORD Eye drop solution containing 0.03% Sodium Flurbiprofen, presented in 2.5ml containers.
• FLUTEL Nasal spray containing 50mcg Fluticasone Propionate, presented in 15ml/120 dose containers.
• FLUZAMED Capsule containing 150mg Fluconazole, presented in 7 or 12 capsule packs, used as an antifungal agent.
• GLYHAT Ophthalmic medical device combining Polyethylene Glycol 400 (PEG 400) and Sodium Hyaluronate for eye lubrication.
• HEPOTEC Capsule containing 140mg Silimarin, used for liver treatment.
• INSULIPON Capsule containing Alpha Lipoic Acid, used for central nervous system support.
• LEVOXIMED Eye and ear drop solution containing 0.5% Levofloxacin Hemihydrate.
• LIMENDA-L Vaginal ovule containing 750mg/200mg/100mg of Metronidazole/Miconazole Nitrate/Lidocaine combination, presented as 7 vaginal ovules.
• LOQULAR Tablet containing Favipiravir, presented in packs of 10, 40, or 100 tablets, used as an antiviral agent.
• MEDEXOL Injectable solution containing Dexamethasone Sodium Phosphate.
• MEDROLGIN Sterile eye drop containing 0.4% Ketorolac Trometamol.
• METACARTIN IM/IV injectable powder presented as ampoules containing 1g/5ml or 2g/10ml, packaged as 5 ampoules or 10 vials.
• METIGAST Capsule containing Simethicone at 40mg for gastrointestinal treatment; also available as 100mg oral drops/emulsion and 100mg/ml drops.
• NASOWELL Nasal spray combining 1mg/ml Xylometazoline Hydrochloride with 50mg/ml Dexpanthenol, presented in 10ml containers.
• OBRAMIS Injectable solution containing Tobramycin.
• ORCAFIL Capsule containing powder for inhalation, presented as 4 tablets.
• PALLADA Eye drop solution containing 6.65mg/ml Olopatadine Hydrochloride, available in 0.1% and 0.2% concentrations in 15ml containers.
• PANTIKOR Capsule containing 400mg Imatinib.
• PARVISTEN Sterile eye drop solution containing 0.025% Ketotifen.
• PASSEAR Ear drops containing 45.52mg/11.38mg/ml Phenazone/Lidocaine Hydrochloride combination, presented in 15ml containers, used for otic conditions.
• PEFSAL Capsule containing powder for inhalation combining 50mcg/500mcg Salmeterol Xinafoate/Fluticasone Propionate, presented as 60 capsules.
• RIMONAL P Eye drop solution containing Brimonidine Tartrate.
• RINOMIL Nasal spray presented in 200 dose format.
• RIZOPROL Film-coated tablet containing 10mg Bisoprolol Fumarate.
• RODINIR Dry powder for oral suspension containing 250mg/5ml Cefdinir.
• ROTACEF Powder for injection (vial) containing 1g Ceftriaxone for I.M. administration.
• SEFPODO Tablet containing Cefpodoxime, presented in 10 and 20 tablet packs.
• SEPTIX Oral spray solution combining 2mg/ml Chlorhexidine digluconate with 0.5mg/ml Lidocaine hydrochloride, presented in 30ml containers, used as antiseptic and analgesic.
• SLEZOL FORTE Eye drop containing 1mg/ml/3mg/ml Dextran 70/Hydroxypropyl Methyl Cellulose combination, presented in 15ml containers.
• SPYLACTON Tablet containing 25mg Spironolactone, presented in 20 or 16 tablet packs.
• TOLPERON Film tablet containing Tolperisone Hydrochloride, presented as 30 tablets, used for musculoskeletal system conditions.
• TRUJEL Injectable gel formulation.
• ULSEPAN Enteric-coated tablet containing 40mg Pantoprazole.
• URSOMED Capsule containing 250mg Ursodeoxycholic Acid, presented in 100 capsule packs; also available as 250ml oral suspension.
• VELP Tablet containing Inosin Pranobeks, presented as 100 tablets.
• VIAMED Tablet containing 50mg Sildenafil Citrate, presented in 2, 4, or 8 tablet packs.
• VITOEL-D3 Vitamin D3 supplement product.
• ZIROMIN Vial containing lyophilised powder with 500mg Azithromycin Dihydrate for IV administration.
• ZOLTONAR Infusion solution containing 5mg/100ml Zoledronic Acid.
• ZONABEC Inhaler product for respiratory treatment.
• AEROLET Herbal cough syrup containing Hedera helix leaf extract, presented in 100ml bottles, classified as a food supplement in the vitamins and minerals category.
• C-MUN Vitamin C effervescent tablet supplement presented as 20 effervescent tablets.
• C-MUN PLUS Food supplement effervescent tablet containing Vitamin C, Vitamin D, and Zinc combination.
• CARBIEM Food supplement oral solution containing L-Carnitine at 2g/10ml dosage.
• ENGILEN Food supplement capsule containing Turmeric, Artichoke, and Thistle combination, presented as 30 capsules.
• GOLD RAY Supplementary food capsule containing Royal Jelly, Garlic, Wheat Germ Oil, and Vitamin A, presented as 20 capsules.
• IMMUNACTIVE Liquid food supplement containing Echinacea Extract, Elderberry Extract, and Vitamin C, presented in 120ml bottles.
• PROSYN Food supplement containing probiotic microorganisms, fibrous food, and multivitamins including Vitamin C, B1, B2, B6, and Fructooligosaccharides (FOS).
• SUGIFEN Liquid food supplement containing multi-vitamins including Vitamin A, B1, B2, B3, B5, B6, B12, C, D, E, and Folic Acid.
• VIADOR Liquid food supplement containing Chicory Extract and Manganese, presented in 150ml bottles.
• VOBIKIDS Food supplement oral solution containing Blueberry extract and extracts of Birch, Schisandra, and Astragalus, with Royal Jelly.
• WM-D3 Food supplement containing 400 I.U. Vitamin D3, presented as 130 puffs or 390 drops.
• Contract Manufacturing Services Full-service pharmaceutical contract manufacturing offering including EU-GMP certified production facilities, sterile and non-sterile manufacturing capabilities, primary and secondary packaging, quality control, and regulatory support across multiple markets including Türkiye and Algeria.

Quantifiable outcome

• 500+ pharmaceutical products across 65+ countries
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators12 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Aspen Pharmacare: South African-headquartered specialty and generic pharmaceutical manufacturer with strong presence across Africa and emerging markets. Comparable geographic focus on developing markets and specialty/generic portfolio.
• Dr. Reddy's Laboratories: India-based integrated pharmaceutical company with strong generics, specialty (including ophthalmology) and API businesses across global emerging and regulated markets. Comparable diversified specialty/generic model.
• Lupin: Indian generic and specialty pharmaceutical company with global manufacturing and significant presence in cardiovascular, respiratory and other specialty areas. Comparable as a specialty generics manufacturer with global ambitions.
• Aurobindo Pharma: Indian generic pharmaceutical manufacturer with global manufacturing and a broad specialty portfolio. Comparable as a vertically integrated generic manufacturer with EU-GMP facilities and worldwide distribution.
• Cipla: India-based global pharmaceutical company with large generics portfolio across respiratory, cardiology, urology and other specialty areas, plus significant emerging market (Africa, Asia) distribution. Comparable business model spanning generics, specialty and emerging market focus.
• Torrent Pharmaceuticals: Indian specialty and generic pharmaceutical manufacturer with therapeutic focus on cardiovascular, central nervous system and gastroenterology. Comparable therapeutic mix and emerging market presence.

Direct peers

• Hikma Pharmaceuticals: Jordan-headquartered, London-listed specialty and generic pharmaceutical manufacturer with strong MENA and emerging markets presence. Closest comparable by combination of branded generics, injectables/inhalation capabilities, and emerging-market distribution footprint.
• Julphar (Gulf Pharmaceutical Industries): UAE-based generic and specialty pharmaceutical manufacturer serving MENA and CIS markets. Highly comparable geographic focus, product mix and emerging market distribution model.
• Abdi İbrahim: Türkiye's largest domestic pharmaceutical company with broad generic and specialty portfolio, EU-GMP facilities and significant export activity. The most direct local competitor to World Medicine within the Turkish pharmaceutical market.

Regional players

• EIPICO (Egyptian International Pharmaceutical Industries): Egypt's largest pharmaceutical manufacturer producing generics across multiple therapeutic categories for MENA and African markets. Comparable business model targeting MENA/Africa with broad specialty generics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/WORLDMEDICINEdz
• YouTubeyoutube.com/@WORLDMEDICINEUNITEDKINGDOM
• Facebookfacebook.com/worldmedicineunitedkingdom
• LinkedInlinkedin.com/company/world-medicine-united-kingdom
• Instagraminstagram.com/worldmedicineunitedkingdom

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about World Medicine